Publications

Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data.

Leclerc, Q; CLEMENTS, A; Dunn, H; Hatcher, J; Lindsay, JA; Grandjean, L; KNIGHT, GM;

2023

Journal of medical microbiology, (2023).72 7 10.1099/jmm.0.001724.

Genomics for public health and international surveillance of antimicrobial resistance.

Baker, KS; Jauneikaite, E; Hopkins, KL; Lo, SW; Sánchez-Busó, L; Getino, M; Howden, BP; HOLT, KE; Musila, LA; Hendriksen, RS; Amoako, DG; Aanensen, DM; Okeke, IN; Egyir, B; Nunn, JG; Midega, JT; Feasey, NA; Peacock, SJ; SEDRIC Genomics Surveillance Working Group,;

2023

The Lancet. Microbe, (2023).4 12 10.1016/s2666-5247(23)00283-5.

Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations.

Baede, VO; Gupta, A; KNIGHT, GM; Schouls, LM; Laing, K; Tavakol, M; Barray, A; De Vlas, SJ; De Vos, AS; Hendrickx, AP A; Khan, M; Kretzschmar, ME; Van Wamel, WJ B; Lina, G; Vandenesch, F; Vos, MC; Witney, AA; Rasigade, J-P; Lindsay, JA;

2023

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, (2023).29 9 10.1016/j.cmi.2023.05.015.

Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data.

Leclerc, Q; Clements, A; Dunn, H; Hatcher, J; Lindsay, JA; Grandjean, L; Knight, GM;

2023

medRxiv (2023). 10.1101/2023.02.15.23285946.

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.

Achar, J; Seddon, JA; KNIGHT, GM; Dodd, PJ; Esmail, H; Hughes, J; MCQUAID, CF;

2023

The European Respiratory Journal, (2023).62 5 10.1183/13993003.00969-2023.

Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study.

Dickson, L; Le Roux, SR; Mitrani, L; Hill, J; Jassat, W; Cox, H; Mlisana, K; Black, J; Loveday, M; GRANT, A; Kielmann, K; Ndjeka, N; Moshabela, M; Nicol, M;

2023

BMJ open, (2023).13 11 10.1136/bmjopen-2022-067121.

Genomics for antimicrobial resistance surveillance to support infection prevention and control in health-care facilities.

Jauneikaite, E; Baker, KS; Nunn, JG; Midega, JT; Hsu, LY; Singh, SR; Halpin, AL; Hopkins, KL; Price, JR; Srikantiah, P; Egyir, B; Okeke, IN; HOLT, KE; Peacock, SJ; Feasey, NA; SEDRIC Genomics Surveillance Working Group,;

2023

The Lancet. Microbe, (2023).4 12 10.1016/s2666-5247(23)00282-3.

Evolution and transmission of antibiotic resistance is driven by Beijing lineage <i>Mycobacterium tuberculosis</i> in Vietnam.

Silcocks, M; Chang, X; Thuong Thuong, NT; Qin, Y; Minh Ha, DT; Khac Thai, PV; Vijay, S; Anh Thu, DD; Ngoc Ha, VT; Ngoc Nhung, H; Huu Lan, N; Quynh Nhu, NT; Edwards, D; Nath, A; Pham, K; Duc Bang, N; Hong Chau, TT; Thwaites, G; Heemskerk, AD; Chuen Khor, C; Teo, YY; Inouye, M; Ong, RT-H; Caws, M; HOLT, KE; ... Dunstan, SJ.

2023

Microbiology spectrum, (2023).11 6 10.1128/spectrum.02562-23.

High-level nitrofurantoin resistance in a clinical isolate of <i>Klebsiella pneumoniae:</i> a comparative genomics and metabolomics analysis.

Hussein, M; Sun, Z; Hawkey, J; Allobawi, R; Judd, LM; Carbone, V; Sharma, R; Thombare, V; Baker, M; Rao, GG; Li, J; HOLT, KE; Velkov, T;

2023

mSystems, (2023).9 1 10.1128/msystems.00972-23.

Typhoid fever.

Meiring, JE; Khanam, F; Basnyat, B; Charles, RC; Crump, JA; Debellut, F; HOLT, KE; Kariuki, S; Mugisha, E; Neuzil, KM; Parry, CM; Pitzer, VE; Pollard, AJ; Qadri, F; Gordon, MA;

2023

Nature reviews. Disease primers, (2023).9 1 10.1038/s41572-023-00480-z.